Hologic Inc
NASDAQ:HOLX
Hologic Inc
Tax Provision
Hologic Inc
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hologic Inc
NASDAQ:HOLX
|
Tax Provision
-$177.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-16%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Tax Provision
-$233m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
2%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Tax Provision
-$436m
|
CAGR 3-Years
-130%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Tax Provision
-$499m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Tax Provision
$6.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Tax Provision
-$336.3m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-10%
|
|
Hologic Inc
Glance View
Hologic Inc., headquartered in Marlborough, Massachusetts, crafts a narrative deeply intertwined with the vital mission of women's health. Established in 1985, the company has grown into a prominent player in the medical device and diagnostics realm. Hologic’s success is anchored in its core business sectors: Breast & Skeletal Health, Diagnostic Solutions, GYN Surgical, and Medical Aesthetics. The cornerstone of this expansive operation is innovation, driving the development of advanced technologies like 3D mammography systems that revolutionize breast cancer detection. This strategic focus on high-value diagnostics and medical equipment allows Hologic to capture significant market share, ensuring a steady revenue stream from both capital equipment sales and ongoing service and maintenance contracts. Beyond its robust presence in imaging and diagnostics, Hologic amplifies its influence through a comprehensive array of solutions for early stage disease detection and treatment. Their Diagnostic Solutions arm, particularly strengthened by molecular diagnostic tests, is a response to the increasing global demand for rapid and accurate testing solutions—a need only intensified by recent global health challenges. These products not only provide critical tools for healthcare professionals but also secure recurring income for Hologic through the sale of consumables and tests. By embedding itself in the cycles of medical advancements and enhancing the standard of care, Hologic generates sustainable growth and remains a crucial ally in both public and specialized health sectors. The company’s blend of technology-driven products and strategic agility enables it to navigate dynamic markets while maintaining a resolute focus on improving health outcomes around the world.
See Also
What is Hologic Inc's Tax Provision?
Tax Provision
-177.3m
USD
Based on the financial report for Dec 28, 2024, Hologic Inc's Tax Provision amounts to -177.3m USD.
What is Hologic Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
-16%
Over the last year, the Tax Provision growth was -57%. The average annual Tax Provision growth rates for Hologic Inc have been 26% over the past three years , and -16% over the past ten years .
You don't have any saved screeners yet